Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
SMS Lifesciences India Ltd. ( (IN:SMSLIFE) ) has shared an announcement.
Haleos Labs Limited has announced the opening of a ‘Special Window’ for the re-lodgment of physical share transfer requests, in compliance with a SEBI circular. This window, open from July 7, 2025, to January 6, 2026, allows shareholders to resubmit transfer requests, facilitating smoother transitions and ensuring regulatory compliance. The initiative reflects the company’s dedication to maintaining transparent and efficient shareholder communication, potentially enhancing stakeholder trust and operational efficiency.
More about SMS Lifesciences India Ltd.
SMS Lifesciences India Limited, now known as Haleos Labs Limited, operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs). The company is committed to providing high-quality pharmaceutical products and services, catering to both domestic and international markets.
Average Trading Volume: 378
Technical Sentiment Signal: Hold
Current Market Cap: 3.38B INR
See more insights into SMSLIFE stock on TipRanks’ Stock Analysis page.